Company news

T.s.investment Corp. (KRX:246690) news

T.s.investment Corp. news releases on 6ix. Latest, Jul 14, 2025: Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS…

View T.s.investment Corp. →

Press releases & updates

Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform

July 14, 2025